Abstract
<div class="authors authors-lg"><div class="author"><div class="author-img"><img src="https://bioinsights.blob.core.windows.net/uploads/C-Quell-66 (2) copy.jpg" data-image="1"></div><div class="author-det"> <b>Bernd Schmidt</b> serves as Vice President, Product Delivery at Quell Therapeutics and has 20 years of industry experience in the pharmaceutical sector, covering a broad range of innovative medicines at different stages in development and post launch. He joined Quell from GSK where he served as MPD Leader with overall accountability for the CMC development, governance and end to end supply chain of a portfolio of medicines (small molecules and cell & gene therapies) covering pre-clinical to late-phase development as well as commercial supply, incl. interactions with regulatory bodies. Prior to that he was the Technical Director and a member of the site leadership team of one of GSK’s main manufacturing facilities in the UK. Before re-joining GSK in 2012 he held roles of increasing responsibility in process and product development at AstraZeneca. </div></div></div>
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
